Cargando…

Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis

Professional society guidelines recommend semiannual screening for hepatocellular carcinoma (HCC) in patients with cirrhosis; however, studies suggest underuse of screening in clinical practice. Our study’s aim was to characterize reasons for HCC screening underuse among patients with cirrhosis. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marquardt, Patrick, Liu, Po‐Hong, Immergluck, Joshua, Olivares, Jocelyn, Arroyo, Ana, Rich, Nicole E., Parikh, Neehar D., Yopp, Adam C., Singal, Amit G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435280/ https://www.ncbi.nlm.nih.gov/pubmed/34510836 http://dx.doi.org/10.1002/hep4.1735

Ejemplares similares

The ITA.LI.CA Staging System: A Novel Staging System for Hepatocellular Carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2016)

A Biomarker Panel Based upon AFP, Fucosylated Kininogen and PEG-Precipitated IgG Is Highly Accurate for the Early Detection Hepatocellular Carcinoma in Patients with Cirrhosis in Phase II and Phase III Biomarker Evaluation
por: Wang, Mengjun, et al.
Publicado: (2022)

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort
por: Parikh, Neehar D., et al.
Publicado: (2022)

A Fucosylated Glycopeptide as a Candidate Biomarker for Early Diagnosis of NASH Hepatocellular Carcinoma Using a Stepped HCD Method and PRM Evaluation
por: Lin, Yu, et al.
Publicado: (2022)

Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic
por: Mehta, Neil, et al.
Publicado: (2021)

Factors associated with unrecognized cirrhosis in patients with hepatocellular carcinoma
por: Lee, Yi-Te, et al.
Publicado: (2023)

PRM-MS Quantitative Analysis of Isomeric N-Glycopeptides Derived from Human Serum Haptoglobin of Patients with Cirrhosis and Hepatocellular Carcinoma
por: Gutierrez Reyes, Cristian D., et al.
Publicado: (2021)

Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization
por: Kassab, Ihab, et al.
Publicado: (2023)

Multidisciplinary care for patients with HCC: a systematic review and meta-analysis
por: Seif El Dahan, Karim, et al.
Publicado: (2023)

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
por: Goossens, Nicolas, et al.
Publicado: (2017)

Glycopeptides with Sialyl Lewis Antigen in Serum Haptoglobin as Candidate Biomarkers for Nonalcoholic Steatohepatitis Hepatocellular Carcinoma Using a Higher-Energy Collision-Induced Dissociation Parallel Reaction Monitoring-Mass Spectrometry Method
por: Lin, Yu, et al.
Publicado: (2022)

Extrahepatic metastasis risk of hepatocellular carcinoma based on α-fetoprotein and tumor staging parameters at cross-sectional imaging
por: Yokoo, Takeshi, et al.
Publicado: (2017)

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
por: Tapper, Elliot B, et al.
Publicado: (2018)

Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
por: Parikh, Neehar D., et al.
Publicado: (2018)

Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response
por: Osho, Azeez, et al.
Publicado: (2020)

Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis
por: Tapper, Elliot B., et al.
Publicado: (2022)

Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies
por: Liang, Jing, et al.
Publicado: (2019)

Comparison of a multitarget blood test to ultrasound and alpha‐fetoprotein for hepatocellular carcinoma surveillance: Results of a network meta‐analysis
por: Singal, Amit G., et al.
Publicado: (2022)

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
por: Singal, Amit G., et al.
Publicado: (2014)

Challenging the Treatment Paradigm: Selecting Patients for Surgical Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Nevarez, Nicole M, et al.
Publicado: (2021)

Comprehensive Health‐State Utilities in Contemporary Patients With Cirrhosis
por: Foster, Chelsey, et al.
Publicado: (2020)

Contemporary management of pain in cirrhosis: Toward precision therapy for pain
por: Holman, Alexis, et al.
Publicado: (2023)

Body Composition Features Predict Overall Survival in Patients With Hepatocellular Carcinoma
por: Singal, Amit G, et al.
Publicado: (2016)

Discovery of Core-Fucosylated Glycopeptides as Diagnostic Biomarkers for Early HCC in Patients with NASH Cirrhosis Using LC-HCD-PRM-MS/MS
por: Tan, Yifei, et al.
Publicado: (2023)

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis
por: Brown, Andrew M., et al.
Publicado: (2022)

Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States
por: Nguyen, Mindie H., et al.
Publicado: (2022)

Incidence of and Risk Factors for Hepatic Encephalopathy in a Population‐Based Cohort of Americans With Cirrhosis
por: Tapper, Elliot B., et al.
Publicado: (2019)

Association between widespread pain and associated symptoms in patients with cirrhosis
por: Holman, Alexis, et al.
Publicado: (2023)

Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience
por: Ju, Michelle R., et al.
Publicado: (2020)

The Utility of Anatomical Liver Resection in Hepatocellular Carcinoma: Associated with Improved Outcomes or Lack of Supportive Evidence?
por: Ju, Michelle, et al.
Publicado: (2019)

A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk
por: Frenette, Catherine T., et al.
Publicado: (2019)

Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
por: Ioannou, George N., et al.
Publicado: (2020)

A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC
por: Cabrera, Roniel, et al.
Publicado: (2020)

Mitotic regulators and the SHP2-MAPK pathway promote IR endocytosis and feedback regulation of insulin signaling
por: Choi, Eunhee, et al.
Publicado: (2019)

Racial, Ethnic, and Socioeconomic Disparities in Curative Treatment Receipt and Survival in Hepatocellular Carcinoma
por: Wagle, Nikita Sandeep, et al.
Publicado: (2021)

Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score
por: Thrift, Aaron P., et al.
Publicado: (2023)

Stool-Based Tests Mitigate Impacts of COVID-19 on Colorectal Cancer Screening
por: Liu, Po-Hong, et al.
Publicado: (2023)

Prediagnostic CT or MRI Utilization and Outcomes in Hepatocellular Carcinoma: SEER-Medicare Database Analysis
por: Karim, Mohammad A., et al.
Publicado: (2023)

Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma
por: Parikh, Neehar D., et al.
Publicado: (2022)

Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study
por: Chhatwal, Jagpreet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j0gdqq2vck5q5truhme4mek4r1